Legal & General Group
ORMP icon

Legal & General Group’s Oramed Pharmaceuticals ORMP Stock Holding History

Legal & General Group’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16K Buy
+3,322
New +$13.2K ﹤0.01% 3202
2022
Q3 		– Sell
-3,022
Closed -$14K – 3476
2022
Q2 		$14K Sell
3,022
-15,720
-84% -$84K ﹤0.01% 3323
2022
Q1 		$162K Buy
18,742
+2,306
+14% +$23.6K ﹤0.01% 2740
2021
Q4 		$234K Buy
16,436
+13,255
+417% +$277K ﹤0.01% 2663
2021
Q3 		$70K Buy
3,181
+354
+13% +$6.03K ﹤0.01% 2908
2021
Q2 		$38K Buy
+2,827
New +$32.3K ﹤0.01% 3044

Other funds holding ORMP

Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80.9B AUM 26.08% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.81B AUM 38.21% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $163M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Legal & General Group's ORMP Position: Q2 2026 in Review

Legal & General Group opened a new position in Oramed Pharmaceuticals (ORMP) in Q2 2026: 3,322 shares worth $16K. The stake represents ﹤0.01% of the portfolio and ranks #3202 among its holdings. This is a return to the name: Legal & General Group previously reported a position in ORMP as recently as Q2 2022.

Legal & General Group first reported a position in ORMP in Q2 2021 and has held it in 6 quarters since. The position peaked at $234K in Q4 2021. 84 funds tracked by Wall St. Rank hold ORMP as of Q2 2026.

  • Legal & General Group held 3,322 shares of Oramed Pharmaceuticals worth $16K as of Q2 2026.
  • Oramed Pharmaceuticals was a new Legal & General Group position in Q2 2026.
  • Oramed Pharmaceuticals made up ﹤0.01% of Legal & General Group's portfolio in Q2 2026, its #3202 holding.
  • Legal & General Group first reported a position in Oramed Pharmaceuticals in Q2 2021 and has held it in 6 quarters since.
  • Legal & General Group's Oramed Pharmaceuticals position peaked at $234K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q2 2026.

Based on Legal & General Group's 13F filing for Q2 2026, filed 14 Aug 2026.